The company’s founder hoped to be able to test the technology on humans this year. In December, Musk said it would be in the next “six months.” Looks like plans will have to change.

Why was it rejected?

Sources said what features of the devices were of concern to the regulator, while the FDA refused to provide a written refusal to Reuters, citing the document’s confidentiality.

announcing his decision The FDA has outlined dozens of issues the company needs to address before testing it in humans.. One of the FDA’s most important claims is the possibility that tiny electrodes can migrate to other parts of the brain. Such wires can cause inflammation, impair functions in critical areas of the brain, and even cause death by tearing blood vessels. Also, FDA officials aren’t sure if the chip can be removed later without damaging the brain.

what is it now

As Reuters notes, the FDA’s rejection has yet to be Doesn’t mean the company’s development is doomed and won’t be approved for future human trials. But to do this will be much more difficult – such a decision indicates the presence of serious doubts.

Musk had previously claimed that the Neuralink device could restore mobility to people with paralysis. However, in February, Dongjin Seo, the company’s co-founder, said the “main short-term goal” for now is to create a feature that will allow paralyzed people to communicate without typing using computerized text.